No effect of vitamin D administration plus dietary intervention on emerging cardiovascular risk factors in patients with metabolic syndrome

Background: Patients with metabolic syndrome (MetS) have low serum 25-hydroxyvitamin D (25(OH)VitD) levels. Low 25(OH)VitD has been associated with several emerging cardiovascular disease (CVD) risk factors, while VitD administration may ameliorate them. Aim: To study the effect of 25(OH)VitD supple...

Full description

Bibliographic Details
Main Authors: Stefania E. Makariou, Moses Elisaf, Anna Challa, Constantinos C. Tellis, Alexandros D. Tselepis, Evangelos N. Liberopoulos
Format: Article
Language:English
Published: Elsevier 2019-06-01
Series:Journal of Nutrition & Intermediary Metabolism
Online Access:http://www.sciencedirect.com/science/article/pii/S2352385918300719